Robert Azelby
2015
In 2015, Robert Azelby earned a total compensation of $9.9M as Executive Vice President, Chief Commercial Officer at Juno Therapeutics.
Compensation breakdown
| Bonus | $800,000 |
|---|---|
| Non-Equity Incentive Plan | $27,667 |
| Option Awards | $6,609,640 |
| Salary | $69,167 |
| Stock Awards | $2,000,006 |
| Other | $406,108 |
| Total | $9,912,588 |
Azelby received $6.6M in option awards, accounting for 67% of the total pay in 2015.
Azelby also received $800K in bonus, $27.7K in non-equity incentive plan, $69.2K in salary, $2M in stock awards and $406.1K in other compensation.
Rankings
In 2015, Robert Azelby's compensation ranked 524th out of 13,638 executives tracked by ExecPay. In other words, Azelby earned more than 96.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 524 out of 13,638 | 96th |
Division Manufacturing | 175 out of 5,187 | 97th |
Major group Chemicals And Allied Products | 68 out of 1,857 | 96th |
Industry group Drugs | 54 out of 1,531 | 97th |
Industry Biological Products, Except Diagnostic Substances | 10 out of 260 | 96th |
Source: SEC filing on April 21, 2017.
Azelby's colleagues
We found four more compensation records of executives who worked with Robert Azelby at Juno Therapeutics in 2015.